January 13, 2026

UCI Health expert urges caution on GLP-1 weight-loss drugs for children

As weight?loss drugs surge in popularity, a UCI Health expert is sounding the alarm about their little known risks for children.

UCI Health

January 09, 2026

The Diagnosis I Couldn’t Deliver: An Oncologist’s Journey Between Roles

As a medical oncologist and palliative care physician, I have spent years preparing for difficult conversations. I’ve guided patients and families through the uncertainty of cancer, helped them naviga...

The ASCO Post

January 08, 2026

A Turning Point in MASH

A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.

The Medicine Maker

January 07, 2026

Inside 2026: The Industry’s AI Turning Point

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

The Medicine Maker

December 30, 2025

Mendelian Randomization: A Powerful Tool — When Used Properly

New TVST editorial examines the promises and Pitfalls of MR in ophthalmology

The Ophthalmologist

December 09, 2025

Hear, Hear to ‘Advancing Geriatric Oncology: Where We Have Been and Where We Are Going’

We read with interest the commentary by Stuart Lichtman, MD, FASCO,on “Advancing Geriatric Oncology: Where We Have Been and Where We Are Going,“ in the October 25, 2025 issue of The ASCO Post.1 Dr. Li...

The ASCO Post

December 04, 2025

Reshaping Drug Development with Mathematical Modeling

Reducing risk, increasing confidence, and enhancing precision through mathematical modeling.

The Medicine Maker

December 04, 2025

ASCO Statement on the Departure of Richard Pazdur, MD, From the FDA

Dr. Pazdur has served the FDA for 26 years and is an expert in drug regulation. He is a longtime ASCO member who has been recognized with the ASCO Service Recognition Award and ASCO Public Service Awa...

The ASCO Post

December 02, 2025

This Week’s CGT News: Advancing Mitochondrial Therapy

Our latest news roundup reports on a partnership to bring cell and gene therapies to underserved communities in India, a new biotech using AI to improve gene editing, and more

The Medicine Maker